| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 10.71▲ | 10.71▲ | 10.71▲ | 10.77▲ | 10.74▲ |
| MA10 | 10.69▲ | 10.68▲ | 10.68▲ | 10.76▲ | 10.71▲ |
| MA20 | 10.65▲ | 10.64▲ | 10.64▲ | 10.73▲ | 10.67▲ |
| MA50 | 10.65▲ | 10.63▲ | 10.63▲ | 10.70▲ | 10.63▲ |
| MA100 | 10.58▲ | 10.57▲ | 10.57▲ | 10.67▲ | N/A |
| MA200 | N/A | N/A | N/A | 10.65▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.010▲ | 0.011▲ | 0.011▲ | 0.006▲ | 0.008▲ |
| RSI | 65.475▲ | 64.924▲ | 64.930▲ | 77.903▲ | 64.954▲ |
| STOCH | 90.509▲ | 91.311▲ | 91.311▲ | 37.466 | 56.188 |
| WILL %R | -7.692▲ | -7.692▲ | -7.692▲ | -45.455 | -28.302 |
| CCI | 100.995▲ | 106.667▲ | 106.667▲ | 153.671▲ | 169.731▲ |
|
Wednesday, August 12, 2026 05:34 AM
Latest SEC filings for Oaktree Acquisition Corp. III Life Sciences (OACC).
|
|
Thursday, August 06, 2026 05:00 PM
Oaktree Acquisition Corp. III Life Sciences is trading at $10.74 per share. As of the most recent reporting period, Oaktree Acquisition Corp. III Life Sciences reported total debt of $11.82K. How much ...
|
|
Thursday, May 14, 2026 10:06 PM
Short interest in Oaktree Acquisition Corp III Life Sciences (NASDAQ:OACC) decreased during the last reporting period, falling from 27.09K to 26.89K. This put 0.14% of the company's publicly available ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/08/26 | 10.80 | 10.80 | 10.80 | 10.80 | 0 |
| 13/08/26 | 10.80 | 10.80 | 10.80 | 10.80 | 595 |
| 12/08/26 | 10.76 | 10.76 | 10.76 | 10.76 | 141 |
| 11/08/26 | 10.74 | 10.74 | 10.74 | 10.74 | 0 |
| 10/08/26 | 10.74 | 10.74 | 10.74 | 10.74 | 1,355 |
| 07/08/26 | 10.74 | 10.74 | 10.74 | 10.74 | 0 |
| 06/08/26 | 10.74 | 10.74 | 10.74 | 10.74 | 0 |
| 05/08/26 | 10.74 | 10.74 | 10.74 | 10.74 | 0 |
| 31/07/26 | 10.75 | 10.77 | 10.74 | 10.74 | 156,232 |
| 30/07/26 | 10.74 | 10.875 | 10.74 | 10.75 | 113,383 |
|
|
||||
|
|
||||
|
|